Related Experiment Video
Updated: Feb 12, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
β-catenin-activated hepatocellular carcinomas are addicted to fatty acids
Nadia Senni1,2,3,4, Mathilde Savall1,2,3,4, David Cabrerizo Granados1,2,3,4
1INSERM, U1016, Institut Cochin, Paris, France.
Objectives:
CTNNB1-mutated hepatocellular carcinomas (HCCs) constitute a major part of human HCC and are largely inaccessible to target therapy. Yet, little is known about the metabolic reprogramming induced by β-catenin oncogenic activation in the liver. We aimed to decipher such reprogramming and assess whether it may represent a new avenue for targeted therapy of CTNNB1-mutated HCC.
Design:
We used mice with hepatocyte-specific oncogenic activation of β-catenin to evaluate metabolic reprogramming using metabolic fluxes on tumourous explants and primary hepatocytes. We assess the role of Pparα in knock-out mice and analysed the consequences of fatty acid oxidation (FAO) using etomoxir. We explored the expression of the FAO pathway in an annotated human HCC dataset.
Results:
β-catenin-activated HCC were not glycolytic but intensively oxidised fatty acids. We found that Pparα is a β-catenin target involved in FAO metabolic reprograming. Deletion of Pparα was sufficient to block the initiation and progression of β-catenin-dependent HCC development. FAO was also enriched in human CTNNB1-mutated HCC, under the control of the transcription factor PPARα.
Conclusions:
FAO induced by β-catenin oncogenic activation in the liver is the driving force of the β-catenin-induced HCC. Inhibiting FAO by genetic and pharmacological approaches blocks HCC development, showing that inhibition of FAO is a suitable therapeutic approach for CTNNB1-mutated HCC.
Insights
Hepatocellular carcinoma (HCC) driven by CTNNB1 mutations relies on fatty acid oxidation (FAO) for growth. Inhibiting FAO effectively blocks tumor development, offering a new therapeutic strategy for CTNNB1-mutated HCC.
Area of Science:
- Hepatocellular carcinoma (HCC) research
- Cancer metabolism
- Molecular oncology
Background:
- CTNNB1-mutated HCC is a significant subtype of liver cancer with limited targeted therapy options.
- The metabolic reprogramming induced by oncogenic beta-catenin activation in HCC remains poorly understood.
- Investigating these metabolic alterations may reveal novel therapeutic targets.
Purpose of the Study:
- To decipher the metabolic reprogramming induced by oncogenic beta-catenin activation in the liver.
- To assess the role of fatty acid oxidation (FAO) in CTNNB1-mutated HCC development.
- To evaluate FAO inhibition as a potential therapeutic strategy for CTNNB1-mutated HCC.
Main Methods:
- Utilized mouse models with hepatocyte-specific beta-catenin activation to study metabolic fluxes.
- Assessed the role of Peroxisome proliferator-activated receptor alpha (PPARα) in knockout mice.
- Analyzed the impact of fatty acid oxidation (FAO) inhibition using etomoxir.
- Explored FAO pathway gene expression in human HCC datasets.
Main Results:
- Beta-catenin-activated HCC exhibited significant fatty acid oxidation (FAO) rather than glycolysis.
- PPARα was identified as a direct beta-catenin target gene crucial for FAO metabolic reprogramming.
- Deletion of PPARα inhibited the initiation and progression of beta-catenin-dependent HCC.
- FAO pathway activation was observed in human CTNNB1-mutated HCC, regulated by PPARα.
Conclusions:
- Fatty acid oxidation (FAO) is the primary driver of beta-catenin-induced HCC.
- Inhibition of FAO, through genetic or pharmacological means, effectively blocks HCC development.
- Targeting FAO presents a promising therapeutic approach for CTNNB1-mutated hepatocellular carcinoma.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Drug Abuse and Addiction: Pharmacological Phenomena
Acid–Base Equilibria: Activity-Based Definition of pH
In solutions of very low ionic strength—for example, pure water—the...
Amino acids
Polyprotic Acids

